The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
Revive Therapeutics (RVV.C) announced they have completed research on and filed a patent application with the United States Patent and Trademark Office (USPTO) on an
Novamind (NM.C) shared the preliminary findings from two studies which involved using Ketamine-Assisted Psychotherapy (KAP) to treat eating disorders. The studies were done in collaboration
Cybin (CYBN.NE) announced that they have successfully demonstrated Proof of Concept for their deuterated tryptamine programs, CYB003 and CYB004. The Proof of Concept revolves around
“2021 will be transformational for the company as we advance the clinical development of our lead product,” added LeDuc.
Information technology is ushering in a new paradigm for the healthcare sector. This is fundamentally changing how and where medical services are rendered, and decisions
Core One Labs (COOL.C) announced they have acquired the Ketamine Infusion Centers of Texas (KITC), a health and wellness clinic that provides ketamine infusion therapy.
Predictmedix (PMED.CN) is a breakout contender. A new uptrend seems to be in the cards backed by NASDAQ listing news. This is what I am patiently waiting for.
Cybin (CYBN.NE) announced changes to the senior management team effective immediately, with some positions being filled by new members of the team and other current
The Nasdaq Exchange has 3,300 listed stocks including giants such as Apple (AAPL.Q), Google (GOOG.Q), Microsoft (MSFT.Q), Oracle (ORCL.Q), Amazon (AMZN.Q), and Intel (INTC.Q).
Nova Mentis Life Science (NOVA.C) announced early indications of a rescue effect through psilocybin use on anxiety-like behaviours related to autism spectrum disorder (ASD). The
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to
Lexaria Bioscience (LXX.C) has provided positive results from its extended stability testing, which has reported unparalleled stability for bottled cannabidiol (CBD)-containing beverages prepared using its
Novamind (NM.C) announced that their wholly-owned subsidiary, Cedar Clinical Research (CCR), has been selected by Merck to be a key research site for a clinical
Core One Labs (COOL.C) announced they filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market. The
Cybin (CYBN.NE) announced they have entered a drug development agreement with Catalent (NYSE: CTLT). Catalent is a global provider for advanced delivery technologies, development, and
Revive Therapeutic (RVV.C) announced they have received positive results from a pre-clinical study evaluating the efficacy of psilocybin for the treatment of mild traumatic brain injury (TBI) in
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America,
Cybin (CYBN.NE) announced they had completed their 20th pre-clinical study and are progressing their CYB003 and CYB004 proprietary psychedelic molecules into studies that will enable
Core One Labs (COOL.C) will begin trading on the OTC Pink Open Market (also known as OTC Pink or Pink Sheets) under the ticker symbol
Core One Labs (COOL.C) announced they have acquired all outstanding share capital of Bluejay Mental Health, a specialty medical clinic with an integrated telehealth platform.
XPhyto Therapeutics (XPHY.C) and its exclusive German diagnostic development partner, 3a-diagnostics GmbH (3a), have announced they received their EN ISO 13485 certification for their rapid
“Molecularly imprinted polymers (MIPs) are synthetic polymers with a predetermined selectivity for a given analyte, or group of structurally related compounds, making them ideal materials to be used in separation processes,” explains Science Direct.
XPhyto (XPHY.C) has successfully completed their corporate rebranding and launched a new website. “The company is excited to introduce a fresh look at such a
Medexus common stock reached a high of $7.70 per share due to a positive market reaction to their latest press release. At a time where
“PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies,” states Medical Device Network, “By detecting viral RNA, which will be present in the body before symptoms of the disease are present,” the tests give a powerful early warning system.
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies
MicroBix Biosystems (MBX.T) develops, manufactures and markets biological products or technologies to customers in North America and around the world. The company is a leading
Nutritional High International (EAT.C) entered into a research services agreement with KGK Science earlier this week through their subsidiary Psychedelic Science (PSC), according to a
Sixth Wave Innovations (SIXW.C) research team finished the first molecular imprint of the SARS-CoV-2 virus using its AMIPs process and technology today, according to a
Buckle up everyone, and get excited – let’s break down Medexus’ latest press release with all its technical details. This is a two-parter, because Medexus
Core One Labs (COOL.C) signed a letter of intent today with Ketamine Infusion Centers of Texas (KICT) today to determine if the company would be
BioVaxys Technology (BIOV.C) announced today that it that it has initiated the clinical trials for Covid-T, the company’s diagnostic platform for detecting T-cell activity, according
The pandemic has sucked, which isn’t really news to anyone. But if you’re anything like the rest of the EG team, you’ve been looking for
Ok weekenders, let’s talk PMED. For the newbies in the room, PMED is PredictMedix Inc, a biotech company Equity Guru’s been working with for the
Empower Clinics (CBDT.C) announced the expansion of their Dallas, Texas, Kai medical laboratory to meet the anticipated growth projections in COVID-19 testing requirements for the
Vancouver media personality, Jody Vance, takes time to speak with Mountain Valley MD (MVMD.C) CEO Dennis Hancock for a detailed picture of the company, its
Pharmadrug (BUZZ.C) signed a binding letter of intent yesterday to acquire biotech firm, Sairiyo Therapeutics, according to a press release. At present, Sairiyo is working
Core One’s objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and addictions.
Much-loved Vancouver media personality, Jody Vance, speaks with Sixth Wave (SIXW.C) president and CEO Jonathan Gluckman to get a good look at the company’s Covid
The stock market has a weird habit of reacting to information in a rapid and uninformed way. This week, Canadian market participants are reacting to an
Before we start, let’s give a big round of applause to Immunoprecise Antibodies Ltd and all its staff and its management. They are headed to
Victory Square Technologies (VST.C) has received the declaration of conformity from the European Union (EU), designating that their COVID-19 rapid test is in compliance with
No need to cut the patient open again later. The surgeon can make adjustments on the fly.
Victory Square Technologies (VST.C) entered into a new sales and distribution contract with a Brazil based medical production and supply company today, according to a
“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives,” stated Saviuk.
In my experience with the North American public markets, few companies and executive teams got more lucky with their shareholder base than Lifestyle Delivery Systems.
On Thursday, December 17th, 2020 the Virtual Life Sciences Investor Forum (VLSIF) presents a six biotech companies.
If this was a 1990’s news website we’d be putting all sorts of animated siren gifs all over the top of this piece because, I
One of Vancouver’s most beloved sports commentators and show hosts, Jody Vance, sits down with leading small cap company CEOs to get a better look
Draganfly (DFLY.C) teamed up with Coldchain Technology Services by selling four Vital Intelligence assessment units to use with its customer base today, according to a
The collaboration will “accelerate the development of psilocybin in the treatment of cancer and the discovery of novel uses of undisclosed psychedelic compounds”.
Markets can ride the COVID-19 vaccine wave for now, but there’s still discovery, development, and the long road to commercialization that lies ahead. PredictMedix ($PMED.C)
Dr. Houghton – a Director and Research Chair holder at Li Ka Shing – just won a Nobel Prize.
Empower Clinics (CBDT.C) announced today that they have received a purchase order for 9,000 of their RT-PCR COVID-19 detection tests, which will be processed over
On November 11, 2020 Revive Therapeutics (RVV.C) Revive Therapeutics updated shareholders on its oral thin-film delivery system with psilocybin being developed “under a research partnership
“We are diligently assembling all the moving pieces in our air quality management solution as current global circumstances call for hyper action in this regard,” stated Martin Kepman, CEO Manganese X, “Breathing virus free air in a contained environment has taken on greater meaning.”
Xphyto Therapeutics (XPHY.C) diagnostic partner, 3a-Diagnostics GmbH, is getting onboard with the latest rush to develop a COVID-19 diagnostic kit, using reverse transcription polymerase chain
SIXW is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the ATLAS AI Project.
“In Canada, it’s not fundamentals, but sentiment that moves markets”…boy, if I had a nickel for everytime I heard that, I would have invested in
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a
Sixth Wave is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ NEW YORK, Oct.
Mind Medicine (MMED.E) is raising money to found and launch a clinical training program focused on developing psychedelic-assisted therapies and medicines at New York University’s
Unless you’ve been living under a rock, you know that Covid-19 took a sledgehammer to corporate profits this summer. So, what the hell did you
Creative Medical Technology Holdings (CELZ.OTC) announced proof of concept studies to demonstrate the efficacy and use-value of their ImmCelz immunotherapy product for the treatment of
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focused on developing coronavirus solutions.
Victory Square Health, a subsidiary of Victory Square Technologies (VST.C), signed into an agreement to purchase a certified laboratory and production facility in Minas Gerais,
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with
As a student of economics, I believe the stock market at times acts like an old-style ‘beauty contest’. This theory is not new but has
Nevro (NVRO.NYSE) announced their intentions to establish global manufacturing operations in Costa Rica to both invest in and support the company’s growth trajectory and expectations.
There’s a million ways to invest, and we’ve covered most of them. You could follow Warren Buffett’s market moves, commit to a specific pattern and
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early pre-symptomatic and asymptomatic stages of infection
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”
Institutional failure at every level of decision making in the United States is why COVID-19 in the world’s largest economy is neither contained nor controlled.
The new economy is digital. It’s in the trillions, so increasing digitization of the world has led to an increased risk that some parts of
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focussed on developing coronavirus solutions.
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled
Willow Biosciences (WLLW.T) is a Canadian biotech company based in Vancouver, BC, that is using “a proprietary yeast strain laboratory process” to produce commercial quantities of CBD and CBG”.
Revive has a partnership agreement with the Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin.
Bio-Techne (TECH.Q), together with Kantaro Biosciences, a commercial affiliate of Mount Sinai Health, announced today the expected release of their COVID-SeroIndex antibody kit. The SeroIndex
CytoSorbents (CTSO.Q) has been awarded a three-year contract valued at $4,421,487 to complete a preclinical development of the HemoDefend plasma and whole blood adsorber by
Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy.
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should
Cognizant’s (CTSH.Q) shared investigator platform (SIP) has reached over 100,00 new users in 84 countries, according to a press release. The software as a service
Edwards Lifesciences Corporation (EW.NYSE) received U.S. Food and Drug Administration (FDA) approval for the KONECT RESILIA aortic valved conduit (AVC) today. The AVC is the
Technology is different from every other sector by virtue of one important factor – it scales. Because technology is scaleable, firms penetrate international markets easily,
Biotech companies especially those tackling Covid-19 are seeing incredible bumps on the boards with companies like Canadian Sona Nanotech (SONA.C), based out of Halifax, Nova
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to do the due diligence for biotechs because it’s “too hard”.
For part I of this series please click here. Cities across Canada are gradually returning to business as usual, and we’re winning the fight against
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto.
The history of humanity is the history of disease. We’ve mostly bumbled around from plague to plague, blind-sided and punch drunk by the ferocity of
3a-Diagnostics, a diagnostic partner for Xphyto Therapeutics (XPHY.C), confirmed the functionality of the peptide biosensors working in Xphyto’s oral dissolvable thin film (ODF) platform today.
Keynes once said that “the market can remain irrational longer than you can remain solvent”. Fundamentals departed market valuation long ago, but you could’ve at least expected market reaction to be in response to COVID-19 related news. Except it seems like that’s no longer the case.
This week’s digest of mushroom moves is a mixed bag of trash and glory, with the shrooms sector increasingly looking like the early days of the cannabis rush.
